Elsamany SA, Elemam O, Hassanin F, Algahami A, Alghanmi H, El naghi KAEA. Neoadjuvant Chemotherapy Plus Denosumab Compared to Chemotherapy Alone in Hormonal Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Premenopausal Breast Cancer Patients. World J Oncol [Internet]. 2025 Aug. 7 [cited 2025 Aug. 17];. Available from: https://wjon.elmerpub.com/wjon/article/view/2546